Herbal extract shows promise for schizophrenia relief
NCT ID NCT07575516
First seen May 09, 2026 · Last updated May 19, 2026 · Updated 1 time
Summary
This study tested whether adding ashwagandha extract to standard schizophrenia treatment (risperidone) can lower inflammation and improve symptoms. 80 male patients with schizophrenia took part. The goal was to see if ashwagandha could reduce a marker of brain inflammation (IL-1β) and improve scores on a symptom rating scale (PANSS). Results may support ashwagandha as a complementary therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROINFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
South Sulawesi Mental Hospital (RSKD Dadi)
Makassar, South Sulawesi, 90245, Indonesia
Conditions
Explore the condition pages connected to this study.